AZN
AstraZeneca PLC
NASDAQ: AZN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$184.74
-1.40% today
Updated 2026-05-01
Market cap
$287.11B
P/E ratio
27.85
P/S ratio
4.89x
EPS (TTM)
$6.65
Dividend yield
—
52W range
$130 – $211
Volume
2.0M
WallStSmart proprietary scores
64
out of 100
Grade: C+
Hold
Investment rating
6.7
Growth
B5.0
Quality
C+8.0
Profitability
A5.3
Valuation
C+6/9
Piotroski F-Score
Moderate
1.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →203 stocks currently score above 75
Price targets
Analyst target
$223.89
+21.19%
12-Month target
$233.94
+26.63%
Intrinsic (DCF)
$214.34
Margin of safety
+3.99%
2 Strong Buy6 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ ROE 22.80% — strong efficiency
+ Free cash flow $1.82B — positive
Risks
- Altman Z 1.48 — distress zone
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $44.35B | $45.81B | $54.07B | $58.74B | $58.74B | $64.8B |
| Net income | $3.29B | $5.96B | $7.04B | $10.26B | $3.08B | — |
| EPS | — | — | — | — | $6.65 | $5.25 |
| Free cash flow | $7.24B | $6.57B | $7.28B | $11.77B | $1.82B | — |
| Profit margin | 7.41% | 13.00% | 13.01% | 17.46% | 17.40% | — |
Peer comparison
Smart narrative
AstraZeneca PLC trades at $184.74. representing a P/E of 27.85x trailing earnings. Our Smart Value Score of 64/100 indicates the stock is good. The company scores 6/9 on the Piotroski F-Score. With an Altman Z-Score of 1.48, it sits in the distress. TTM revenue stands at $58.74B. with profit margins at 17.40%. Our DCF model estimates intrinsic value at $214.34.
Frequently asked questions
What is AstraZeneca PLC's stock price?
AstraZeneca PLC (AZN) trades at $184.74.
Is AstraZeneca PLC overvalued?
Smart Value Score 64/100 (Grade C+, Hold). DCF value $214.34.
What is the price target of AstraZeneca PLC (AZN)?
The analyst target price is $223.89, representing +21.2% upside from the current price of $184.74.
What is the intrinsic value of AstraZeneca PLC (AZN)?
Based on our DCF model, intrinsic value is $214.34, a +4.0% margin of safety versus $184.74.
What is the future stock price of AZN by 2030?
Our research-backed model estimates AstraZeneca PLC could reach $208.73 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is AstraZeneca PLC's revenue?
TTM revenue is $58.74B.
Piotroski F-Score?
6/9 — moderate financial health.
Altman Z-Score?
1.48 — distress.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - GENERAL
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio4.89x
ROE22.80%
Beta0.28
50D MA$196.94
200D MA$176.83
Shares out1.55B
Float1.54B
Short ratio—
Avg volume2.0M
Performance
1 week-1.48%
1 month-9.21%
3 months-1.95%
YTD+100.96%
1 year—
3 years—
5 years—